EMEA-001729-PIP02-18
Key facts
Invented name |
Oxervate
|
Active substance |
Cenegermin
|
Therapeutic area |
Ophthalmology
|
Decision number |
P/0118/2019
|
PIP number |
EMEA-001729-PIP02-18
|
Pharmaceutical form(s) |
Eye drops, solution
|
Condition(s) / indication(s) |
Treatment of dry eye disease
|
Route(s) of administration |
Ocular use
|
Contact for public enquiries |
Dompé farmaceutici S.p.A.
E-mail: annabella.amatulli@dompe.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|